Clinical Trial Update: POISE Trial: Perioperative Ischemic Evaluation Study [Phase 3]

View source ↗

Summary

This clinical trial update reports that the POISE Phase 3 trial evaluating perioperative ischemic outcomes with metoprolol tartrate has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases

Drugs mentioned

• METOPROLOL TARTRATE (METOPROLOL TARTRATE)

Snippet

Sponsor: Hamilton Health Sciences Corporation | Conditions: Cardiovascular Diseases | Phase 3 | Status: TERMINATED